Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer

Abstract Background The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to assess its association with patient prognosis and treatment response. Methods We first analyzed the differential expressio...

Full description

Bibliographic Details
Main Authors: Jun Li, Huiran Yue, Hailin Yu, Xin Lu, Xiaohong Xue
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cancer
Subjects:
Ovarian cancer
NNMT
Prognosis
Nomogram
Bevacizumab
Online Access:https://doi.org/10.1186/s12885-021-07785-w

Similar Items

Similar Items